Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

EASD Insights: Long-term Complications in Diabetes - From Classical …

Stephan Herzig

Assessment of Liver Lesions

Houston Methodist

T. Basra

Pregnancy-Induced TMA Case Discussion: Atypical HUS/Complement-Media…

USTMA - The United States Thrombotic Microangiopathy Consortium

A. Java, A. Antun, R. Burwick

Cisplatin-induced Nephrotoxicity: Models, Mechanisms, and Comorbidit…

University of Louisville

L. J. Siskind

Approach to the Patient with a Liver Mass

Cedars Sinai

W. Ayoub

Hepatocellular Cancer Treatments

Rush University Medical Center

S. Eswaran

Pregnancy-Induced TMA Case Discussion: Atypical HUS/Complement-Media…

USTMA - The United States Thrombotic Microangiopathy Consortium

A. Java, A. Antun, R. Burwick

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

Paris System 2.0: Highlights and Updates in Urinary Cytology

Houston Methodist

M. T. Siddiqui

Update on Biomarkers for Liver Cancer Screening

UCLA Health

V. Agopian

Shifting Paradigms: Exploring Enarodustat for Anemia in Chronic Kidn…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

A. Sarici

The Path Ahead: Imaging-Based Hepatology

Yale School of Medicine

J. Weinreb

Systemic Therapy for Hepatocellular Carcinoma

UPMC

J. Rhee

ASH 2021 Updates on Morbidity & Mortality Associated With Hemodialys…

ASH 2021 Conference Coverage on VuMedi

M. Osei

Liver Directed Therapy in 2021: What Are the Advances in Transarteri…

UCLA Health

S. Padia

Management of Colorectal Cancer Liver Metastases

Houston Methodist

C. Hambleton Davis

NW AASLD Review 2021: Cirrhotic Complications

Northwestern Medicine Gastroenterology

C. Moore

Advances in the Treatment of Hepatocellular Carcinoma

UCLA Health

S. Sadeghi